These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 34299145)
1. Diagnostic Tools and Biomarkers for Severe Drug Eruptions. Yoshioka M; Sawada Y; Nakamura M Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299145 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic criteria for cutaneous adverse drug reactions]. Aihara M Arerugi; 2012 Aug; 61(8):1061-6. PubMed ID: 23089970 [No Abstract] [Full Text] [Related]
11. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Anderson HJ; Lee JB Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848 [TBL] [Abstract][Full Text] [Related]
12. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases. Bellón T; Alvarez L; Mayorga C; Morel E; Torres MJ; Martín-Díaz MA; Díaz R; Radial A; Carballo M; Blanca M Br J Dermatol; 2010 May; 162(5):1014-22. PubMed ID: 20030638 [TBL] [Abstract][Full Text] [Related]
14. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders. Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH; J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642 [TBL] [Abstract][Full Text] [Related]
15. Life-threatening acute adverse cutaneous drug reactions. Wolf R; Orion E; Marcos B; Matz H Clin Dermatol; 2005; 23(2):171-81. PubMed ID: 15802211 [TBL] [Abstract][Full Text] [Related]
16. Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions. Chu MT; Wang CW; Chang WC; Chen CB; Chung WH; Hung SI J Invest Dermatol; 2021 Jun; 141(6):1461-1472.e10. PubMed ID: 33340500 [TBL] [Abstract][Full Text] [Related]
17. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome. Harr T; French LE Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860 [TBL] [Abstract][Full Text] [Related]
18. Stevens-Johnson Syndrome: A Challenging Diagnosis. Davis WD; Schafer PA Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372 [TBL] [Abstract][Full Text] [Related]
19. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644 [TBL] [Abstract][Full Text] [Related]
20. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)]. Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]